Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72051 - 72075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	P2RY2	5029	upregulated	Silicon Dioxide analog results in increased expression of P2RY2 mRNA	11q13.4	A24195
Silicon dioxide	Approved	P2RY2	5029	downregulated	Silicon Dioxide results in decreased expression of P2RY2 mRNA	11q13.4	A24196
Silicon dioxide	Approved	P2RY6	5031	downregulated	Silicon Dioxide analog results in decreased expression of P2RY6 mRNA	11q13.4	A24195
Silicon dioxide	Approved	P4HA3	283208	downregulated	Silicon Dioxide analog results in decreased expression of P4HA3 mRNA	11q13.4	A24195
Silicon dioxide	Approved	P4HTM	54681	downregulated	Silicon Dioxide analog results in decreased expression of P4HTM mRNA	3p21.31	A24195
Silicon dioxide	Approved	PA2G4	5036	upregulated	Silicon Dioxide analog results in increased expression of PA2G4 mRNA	12q13.2	A24195
Silicon dioxide	Approved	PABPC1L	80336	downregulated	Silicon Dioxide analog results in decreased expression of PABPC1L mRNA	20q13.12	A24194
Silicon dioxide	Approved	PABPC1L	80336	upregulated	Silicon Dioxide analog results in increased expression of PABPC1L mRNA	20q13.12	A24195
Silicon dioxide	Approved	PABPC4L	132430	downregulated	Silicon Dioxide analog results in decreased expression of PABPC4L mRNA	4q28.3	A24195
Silicon dioxide	Approved	PACRGL	133015	upregulated	Silicon Dioxide analog results in increased expression of PACRGL mRNA	4p15.31	A24195
Silicon dioxide	Approved	PACSIN1	29993	downregulated	Silicon Dioxide analog results in decreased expression of PACSIN1 mRNA	6p21.3	A24195
Silicon dioxide	Approved	PACSIN3	29763	upregulated	Silicon Dioxide analog results in increased expression of PACSIN3 mRNA	11p11.2	A24194
Silicon dioxide	Approved	PADI2	11240	upregulated	Silicon Dioxide analog results in increased expression of PADI2 mRNA	1p36.13	A24195
Silicon dioxide	Approved	PADI3	51702	upregulated	Silicon Dioxide analog results in increased expression of PADI3 mRNA	1p36.13	A24195
Silicon dioxide	Approved	PAEP	5047	downregulated	Silicon Dioxide analog results in decreased expression of PAEP mRNA	9q34.3	A24195
Silicon dioxide	Approved	PAG1	55824	upregulated	Silicon Dioxide analog results in increased expression of PAG1 mRNA	8q21.13	A24194
Silicon dioxide	Approved	PAGE2	203569	upregulated	Silicon Dioxide analog results in increased expression of PAGE2 mRNA	Xp11.21	A24194
Silicon dioxide	Approved	PAGE2B	389860	downregulated	Silicon Dioxide analog results in decreased expression of PAGE2B mRNA	Xp11.21	A24195
Silicon dioxide	Approved	PAGE5	90737	upregulated	Silicon Dioxide analog results in increased expression of PAGE5 mRNA	Xp11.21	A24194
Silicon dioxide	Approved	PAIP1	10605	downregulated	Silicon Dioxide results in decreased expression of PAIP1 mRNA	5p12	A24196
Silicon dioxide	Approved	PAIP2B	400961	downregulated	Silicon Dioxide analog results in decreased expression of PAIP2B mRNA	2p13.3	A24195
Silicon dioxide	Approved	PALD1	27143	upregulated	Silicon Dioxide analog results in increased expression of PALD1 mRNA	10q22.1	A24195
Silicon dioxide	Approved	PALMD	54873	downregulated	Silicon Dioxide analog results in decreased expression of PALMD mRNA	1p21.2	A24195
Silicon dioxide	Approved	PALMD	54873	downregulated	Silicon Dioxide results in decreased expression of PALMD mRNA	1p21.2	A24196
Silicon dioxide	Approved	PAMR1	25891	downregulated	Silicon Dioxide results in decreased expression of PAMR1 mRNA	11p13	A24196

Displaying entries 72051 - 72075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability